SPY757.04−0.36%QQQ685.21−0.75%BTC/USD73,342.97−0.79%DIA525.02+0.11%GLD362.14−0.83%TLT80.99+0.09%

AdaptHealth Corp

AHCONASDAQ

Trade with Public

$7.80

0.081.04%

Last update: Nov 11, 4:00 PM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

AdaptHealth (AHCO) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for AdaptHealth (AHCO) stock.

Analyst Consensus — 7 Analysts

7Buy

# Analysts7

Latest Upgrades and Downgrades for AdaptHealth Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Leerink Partners	Whit Mayo	PT Raise	Outperform	$7→$8
—	UBS	Kevin Caliendo	PT Cut	Buy	$10→$9
—	Baird	Eric Coldwell	PT Cut	Outperform	$10→$9
—	UBS	Kevin Caliendo	PT Cut	Buy	$14→$10
—	RBC Capital	Ben Hendrix	PT Cut	Outperform	$15→$8
—	Truist Securities	David Macdonald	PT Cut	Buy	$14→$9
—	Jefferies	Brian Tanquilut	Upgrade	Hold→Buy	$11→$13
—	Baird	Eric Coldwell	PT Cut	Outperform	$18→$15
—	RBC Capital	Ben Hendrix	PT Raise	Outperform	$13→$15
—	Canaccord Genuity	Richard Close	PT Raise	Buy	$14→$16
—	UBS	Kevin Caliendo	PT Cut	Buy	$15→$14
—	Truist Securities	David Macdonald	PT Raise	Buy	$13→$14
—	Leerink Partners	Whit Mayo	PT Cut	Outperform	$13→$12
—	Canaccord Genuity	Richard Close	PT Raise	Buy	$14→$15
—	Truist Securities	David Macdonald	PT Cut	Buy	$14→$13
—	RBC Capital	Ben Hendrix	PT Cut	Outperform	$14→$13
—	Baird	Eric Coldwell	PT Raise	Outperform	$14→$16
—	Canaccord Genuity	Richard Close	PT Raise	Buy	$13→$14
—	RBC Capital	Ben Hendrix	PT Raise	Outperform	$11→$14
—	Truist Securities	David Macdonald	PT Raise	Buy	$12→$14

AdaptHealth Corp

AdaptHealth (AHCO) Stock Price Target 2026

Latest Upgrades and Downgrades for AdaptHealth Stock

AdaptHealth (AHCO) Stock Price Target 2026

Latest Upgrades and Downgrades for AdaptHealth Stock

Analyst Ratings News

PRO
Leerink Partners Maintains Outperform on AdaptHealth, Raises Price Target to $8

PRO
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $9

PRO
Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9

PRO
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $10

PRO
RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $8

PRO
Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9

People Also Watch

People Also Watch

Analyst Ratings News

PRO
Leerink Partners Maintains Outperform on AdaptHealth, Raises Price Target to $8

PRO
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $9

PRO
Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9

PRO
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $10

PRO
RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $8

PRO
Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9

AdaptHealth Corp

AdaptHealth (AHCO) Stock Price Target 2026

Latest Upgrades and Downgrades for AdaptHealth Stock

AdaptHealth (AHCO) Stock Price Target 2026

Latest Upgrades and Downgrades for AdaptHealth Stock

Analyst Ratings News

PROLeerink Partners Maintains Outperform on AdaptHealth, Raises Price Target to $8

PROUBS Maintains Buy on AdaptHealth, Lowers Price Target to $9

PROBaird Maintains Outperform on AdaptHealth, Lowers Price Target to $9

PROUBS Maintains Buy on AdaptHealth, Lowers Price Target to $10

PRORBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $8

PROTruist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9

People Also Watch

People Also Watch

Analyst Ratings News

PROLeerink Partners Maintains Outperform on AdaptHealth, Raises Price Target to $8

PROUBS Maintains Buy on AdaptHealth, Lowers Price Target to $9

PROBaird Maintains Outperform on AdaptHealth, Lowers Price Target to $9

PROUBS Maintains Buy on AdaptHealth, Lowers Price Target to $10

PRORBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $8

PROTruist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9

PRO
Leerink Partners Maintains Outperform on AdaptHealth, Raises Price Target to $8

PRO
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $9

PRO
Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9

PRO
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $10

PRO
RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $8

PRO
Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9

PRO
Leerink Partners Maintains Outperform on AdaptHealth, Raises Price Target to $8

PRO
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $9

PRO
Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9

PRO
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $10

PRO
RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $8

PRO
Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9